| Trial ID: | L4575 |
| Source ID: | NCT00704236
|
| Associated Drug: |
Coptis Chinensis, Astragalus Mambranesceus, Lonicera Japonica (Traditional Chinese Treatment)
|
| Title: |
Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Coptis Chinensis, Astragalus mambranesceus, Lonicera Japonica (Traditional Chinese Treatment)|DRUG: Placebo
|
| Outcome Measures: |
Primary: Glucose Disposal Rate | Secondary: Fasting Plasma Glucose,Postprandial Plasma Glucose,HbA1c,triglyceride,cholesterol,HDL-c and LDL-c,lipid levels ,body weight, blood pressure
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
43
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-09
|
| Completion Date: |
2008-02
|
| Results First Posted: |
|
| Last Update Posted: |
2008-12-11
|
| Locations: |
Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00704236
|
